Corpus ID: 32748938

Gateways to clinical trials.

@article{Bayes2004GatewaysTC,
  title={Gateways to clinical trials.},
  author={M. Bayes and X. Rabasseda and J. Prous},
  journal={Methods and findings in experimental and clinical pharmacology},
  year={2004},
  volume={26 5},
  pages={
          357-91
        }
}
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies Knowledge Area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com. This issue focuses on the following selection of drugs: 101M; Adalimumab, adefovir dipivoxil, adenosine triphosphate, albumin interferon alfa, alefacept, alemtuzumab, aminolevulinic acid hexyl… Expand
51 Citations
Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
  • 24
  • Highly Influenced
  • PDF
SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV
  • 157
  • Highly Influenced
  • PDF
Metformin protects against sevoflurane-induced neuronal apoptosis through the S1P1 and ERK signaling pathways.
  • 2
21 Highlights of Natural Products in Prostate Cancer Drug Discovery
  • PDF
Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.
  • PDF
Protein PEGylation for cancer therapy: bench to bedside
  • 6
...
1
2
3
4
5
...